サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1636020

エピネフリン自己注射器市場レポート：用量別、用途別、エンドユーザー別、地域別、2025-2033年

Epinephrine Autoinjector Market Report by Dosage, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 124 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
エピネフリン自己注射器市場レポート：用量別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年01月10日
発行: IMARC
ページ情報: 英文 124 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

エピネフリン自己注射器市場の世界市場規模は2024年に26億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに53億米ドルに達し、2025年から2033年にかけて7.8%の成長率（CAGR）を示すと予測しています。アレルギーを持つ個人の増加、自己投与医薬品のニーズの高まり、スマートエピネフリン自己注射器の発売は、市場を牽引する主な要因のいくつかです。

エピネフリン自己注射器は、刺され、虫刺され、または薬剤によって引き起こされる重度のアレルギー反応を治療するために、単回投与エピネフリンを簡単に投与するために使用される医療機器です。エピネフリン自己注射器は、大腿部の筋肉に薬剤を投与するように設計されており、血管を収縮させ、気道を拡張させることにより、アレルギー反応の症状を最小限に抑えます。小型で携帯しやすく、個人でもヘルスケア専門家でも投与できます。現在、大手メーカーはエピネフリン自己注射器に複数回投与可能な薬剤や、使用者がアレルギー反応の重症度に応じて投与量を調節し、治療効果を向上させることができる調節可能な投与量を導入しています。また、個人が緊急時に使用しやすいように、音声や視覚による説明も取り入れられています。

エピネフリン自己注射器市場傾向：

アレルギーやアレルギー反応を持つ人の増加や、自己投与薬のニーズの高まりは、世界中でエピネフリン自己注射器の需要を促進している主な要因の一つです。さらに、関節炎、喘息、がん、慢性閉塞性肺疾患（COPD）の有病率の急増と、アレルギー反応を発症しやすい高齢化人口の開拓が、市場にプラスの影響を与えています。さらに、大衆の間で食物アレルギーの発生率が増加していることも、市場の成長を後押ししています。これとは別に、多くの国の行政機関が、学校やその他の公共スペースでのエピネフリン自己注射器の使用を促進するための取り組みを行っています。このことは、エピネフリン自己注射器に関する意識の高まりと相まって、市場の成長に寄与しています。さらに、主要企業は、Bluetooth接続、センサー、機械学習などの先進技術を統合したスマートエピネフリン自己注射器を導入し、より便利で使いやすく、効果的なものにしています。大手企業はまた、スマートフォンやその他のデバイスに接続可能なモバイルアプリケーションを発表しており、遠隔監視、使用量や使用期限の追跡、患者が推奨用量を超えないようにすることを可能にしています。これらの進歩は、アレルギー反応の可能性を予測し、治療のための個別化された推奨を提供するのにも役立ちます。これに加えて、エピネフリン自己注射器に自動体外式除細動器（AED）を組み込んで包括的な緊急対応システムを提供することで、市場の見通しは明るくなっています。

本レポートで扱う主な質問

  • 世界のエピネフリン自己注射器市場はこれまでどのように推移してきたのか？
  • 世界のエピネフリン自己注射器市場における促進要因、抑制要因、機会は何か？
  • 各促進要因、抑制要因、機会がエピネフリン自己注射器市場の世界に与える影響とは？
  • 主要地域市場とは？
  • 最も魅力的なエピネフリン自己注射器市場はどの国か？
  • 用量別の市場内訳は？
  • エピネフリン自己注射器市場で最も魅力的な用量は？
  • 用途別の市場内訳は？
  • エピネフリン自己注射器市場で最も魅力的な用途は？
  • エンドユーザー別の市場内訳は？
  • エピネフリン自己注射器市場で最も魅力的なエンドユーザーは？
  • 世界のエピネフリン自己注射器市場の競合構造は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のエピネフリン自己注射器市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：用量別

  • 0.15mgエピネフリン自動注射器
    • 市場動向
    • 市場予測
  • 0.3mgエピネフリン自動注射器
    • 市場動向
    • 市場予測
  • 0.5mgエピネフリン自動注射器
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 6歳未満
    • 市場動向
    • 市場予測
  • 6～12歳
    • 市場動向
    • 市場予測
  • 12歳超
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 促進要因・抑制要因・機会

  • 概要
  • 促進要因
  • 抑制要因
  • 機会

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Adamis Pharmaceuticals Corporation
    • Amneal Pharmaceuticals Inc.
    • Antares Pharma Inc
    • Bausch Health
    • Kaleo Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
図表

List of Figures

  • Figure 1: Global: Epinephrine Autoinjector Market: Major Drivers and Challenges
  • Figure 2: Global: Epinephrine Autoinjector Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Epinephrine Autoinjector Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Epinephrine Autoinjector Market: Breakup by Dosage (in %), 2024
  • Figure 5: Global: Epinephrine Autoinjector Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Epinephrine Autoinjector Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Epinephrine Autoinjector Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Epinephrine Autoinjector (0.15mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Epinephrine Autoinjector (0.3mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Epinephrine Autoinjector (0.5mg Epinephrine Autoinjector) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Epinephrine Autoinjector (Under 6 Years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Epinephrine Autoinjector (Under 6 Years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Epinephrine Autoinjector (6 to 12 Years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Epinephrine Autoinjector (6 to 12 Years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Epinephrine Autoinjector (Over 12 Years) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Epinephrine Autoinjector (Over 12 Years) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Epinephrine Autoinjector (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Epinephrine Autoinjector (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Epinephrine Autoinjector (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Epinephrine Autoinjector (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Epinephrine Autoinjector (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Epinephrine Autoinjector (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Epinephrine Autoinjector Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Epinephrine Autoinjector Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Epinephrine Autoinjector Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Epinephrine Autoinjector Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Epinephrine Autoinjector Industry: Value Chain Analysis
  • Figure 77: Global: Epinephrine Autoinjector Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epinephrine Autoinjector Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Epinephrine Autoinjector Market Forecast: Breakup by Dosage (in Million USD), 2025-2033
  • Table 3: Global: Epinephrine Autoinjector Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Epinephrine Autoinjector Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Epinephrine Autoinjector Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Epinephrine Autoinjector Market: Competitive Structure
  • Table 7: Global: Epinephrine Autoinjector Market: Key Players
目次
Product Code: SR112025A7369

The global epinephrine autoinjector market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2033, exhibiting a growth rate (CAGR) of 7.8% during 2025-2033. The increasing number of individuals with allergies, rising need for self-administrating medicines, and the launch of smart epinephrine autoinjector represent some of the key factors driving the market.

Epinephrine autoinjector is a medical device used to administer single dose epinephrine easily for treating severe allergic reactions caused by stings, bug bites, or drugs. It is designed to deliver the medication into the thigh muscle of an individual and works by constricting blood vessels and dilating the airways to minimize the symptoms of an allergic reaction. It is small and easy to carry and can be administered by individuals or healthcare professionals. At present, leading manufacturers are introducing epinephrine autoinjector with multiple doses of medications and adjustable dosages that enable the user to adjust the dose according to the severity of the allergic reaction and improve the effectiveness of the treatment. They are also incorporating audio and visual instructions to make it easier for individuals to use them in an emergency.

Epinephrine Autoinjector Market Trends:

The increasing number of individuals with allergies and allergic reactions and the rising need for self-administrating medicines represent one of the major factors driving the demand for epinephrine autoinjectors around the world. Moreover, the surging prevalence of arthritis, asthma, cancer, and chronic obstructive pulmonary disease (COPD) and the growing aging population, which is more prone to develop allergic reactions, is influencing the market positively. In addition, the increasing incidence of food allergies among the masses is bolstering the growth of the market. Apart from this, governing agencies of numerous countries are undertaking initiatives to promote the use of epinephrine autoinjectors in schools and other public spaces. This, coupled with the rising awareness about epinephrine autoinjectors, is contributing to the market growth. Furthermore, key players are introducing smart epinephrine autoinjectors that are integrated with advanced technologies, including Bluetooth connectivity, sensors, and machine learning, to make them more convenient, user friendly, and effective. Leading players are also launching mobile applications that can be connected to smartphones or other devices, allowing remote monitoring, tracking of usage and expiration dates, and ensuring the patient does not exceed the recommended dosage. These advancements can also help predict the likelihood of an allergic reaction and provide personalized recommendations for treatment. This, along with the incorporation of an automated external defibrillator (AED) in epinephrine autoinjectors to offer a comprehensive emergency response system, is creating a positive outlook for the market.

Key Market Segmentation:

Dosage Insights:

  • 0.15mg Epinephrine Autoinjector
  • 0.3mg Epinephrine Autoinjector
  • 0.5mg Epinephrine Autoinjector

Application Insights:

  • Under 6 Years

6 to 12 Years

  • Over 12 Years

End User Insights:

  • Hospitals
  • Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for epinephrine autoinjectors. Some of the factors driving the North America epinephrine autoinjector market included the rising prevalence of allergies, increasing awareness about anaphylaxis, and the availability of cost-effective generic versions of autoinjectors.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global epinephrine autoinjector market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Adamis Pharmaceuticals Corporation, Amneal Pharmaceuticals Inc., Antares Pharma Inc, Bausch Health, Kaleo Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global epinephrine autoinjector market performed so far, and how will it perform in the coming years ?
  • What are the drivers, restraints, and opportunities in the global epinephrine autoinjector market ?
  • What is the impact of each driver, restraint, and opportunity on the global epinephrine autoinjector market ?
  • What are the key regional markets ?
  • Which countries represent the most attractive epinephrine autoinjector markets ?
  • What is the breakup of the market based on the dosage ?
  • Which is the most attractive dosage in the epinephrine autoinjector market ?
  • What is the breakup of the market based on the application ?
  • Which is the most attractive application in the epinephrine autoinjector market ?
  • What is the breakup of the market based on the end user ?
  • Which is the most attractive end user in the epinephrine autoinjector market ?
  • What is the competitive structure of the global epinephrine autoinjector market ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epinephrine Autoinjector Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Dosage

  • 6.1 0.15mg Epinephrine Autoinjector
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 0.3mg Epinephrine Autoinjector
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 0.5mg Epinephrine Autoinjector
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Under 6 Years
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 6 to 12 Years
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Over 12 Years
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adamis Pharmaceuticals Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Amneal Pharmaceuticals Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Antares Pharma Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Bausch Health
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Kaleo Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Teva Pharmaceutical Industries Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Viatris Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.